Clinical Trials Logo

Filter by:
NCT ID: NCT05477108 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Start date: July 29, 2022
Phase: Phase 1
Study type: Interventional

The study will assess the Pharmacokinetic (PK) and safety of BGF MDI [Budesonide/glycopyrronium/formoterol (BGF) metered dose inhaler (MDI)] formulated with 2 different propellants :Hydrofluoroolefin (HFO) and Hydrofluoroalkane (HFA) with oral activated charcoal in healthy subjects (male or female).

NCT ID: NCT05477056 Completed - Alzheimer Disease Clinical Trials

Quality Improvement PrecivityAD Clinician Survey (QUIP I)

QUIP I
Start date: March 1, 2021
Phase:
Study type: Observational

There is an important unmet need for timely, non-invasive, and low-burden evaluation of patients presenting with mild cognitive impairment (MCI) and early dementia. MCI impacts 12-18% of people in the United States over age 60 and is often an initial clinical sign of Alzheimer's disease (AD) (Alzheimer's Association, 2022). The PrecivityAD test is an analytically and clinically validated blood test that aids healthcare providers in the diagnosis of AD in patients with MCI and early-stage dementia. C2N has created a quality improvement (QI) survey to gather insight from clinicians as to the clinical effectiveness of the commercially available PrecivityAD™ test, which identifies whether a patient with signs and symptoms of cognitive decline is likely to have amyloid plaques in the brain, a pathological hallmark of Alzheimer's disease.

NCT ID: NCT05476679 Completed - Submental Fat Clinical Trials

Evaluation the Effects of Various Treatments on RZL-012-Induced Adverse Events

Start date: September 25, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase 2, open-label, 2-stage, adaptive-design study in which subjects will be randomized into one of 5 treatment groups comprised of RZL-012 with or without additional study treatments:

NCT ID: NCT05476614 Completed - Clinical trials for Testing the Efficacy of Social Robot-led Yoga

Testing the Efficacy of Social Robot-led Yoga

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Research demonstrates that yoga is beneficial for the older adults with or nearing mild cognitive impairment. Social robots are increasingly being used as companions and caregivers for older adults with or nearing MCI . The purpose of this study is to test the efficacy of social robot-led yoga for older adults with or nearing MCI. The study hypothesizes that social robot-led yoga is similar in effectiveness to human-led yoga across a range of measures.

NCT ID: NCT05476562 Completed - Clinical trials for Chronic Myeloid Leukemia

Study Conducted Among Patients With CML

Start date: March 8, 2021
Phase:
Study type: Observational

Retrospective, non-interventional observational cohort study conducted among patients with CML.

NCT ID: NCT05476406 Completed - Skin Hydration Clinical Trials

Clinical Study to Evaluate the Impact of aKwa Skincare System on Skin Health

Start date: April 11, 2019
Phase: N/A
Study type: Interventional

The purpose of the study was to evaluate the effectiveness of the äKwä 6-step skincare system by measuring skin moisture level, fine lines and wrinkles, porphyrin count, red spots, and red vasculature counts over a 30-day period.

NCT ID: NCT05475457 Completed - Clinical trials for Evidence-Based Practice

Oregon Supplement: Supporting Sustainable Positive Interactions in the Child Welfare System: The R3 Supervisor Strategy

Start date: April 8, 2019
Phase:
Study type: Observational

This administrative supplement capitalized on the preliminary positive outcomes from the primary parent grant award (R01DA040416), and lessons learned from the implementation of the R3 Supervisor Strategy (R3) throughout the participating four regions (12 counties) in Tennessee. This project aimed to pilot the implementation of R3 with a new sample, a cohort of counties in Oregon particularly affected by the current opioid epidemic, for potential scale-up.

NCT ID: NCT05473585 Completed - Smoking Clinical Trials

Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2

Start date: October 12, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate how limiting the nicotine content in regular cigarettes affects choices for regular cigarette and e-cigarette products. Eligible participants will be of legal age to purchase tobacco products and regularly use both e-cigarettes and regular cigarettes.

NCT ID: NCT05473026 Completed - Exercise Clinical Trials

Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors

Start date: November 8, 2022
Phase: N/A
Study type: Interventional

This pilot study will assess the feasibility of a gratitude intervention to promote physical activity, and well-being and positively impact biomarkers of health among older African American breast cancer survivors. The intervention will also include a goal-setting component to promote exercise readiness and examine the cultural phenomena of the Superwoman schema among Black women.

NCT ID: NCT05472935 Completed - Quality of Life Clinical Trials

Asynchronous Mindfulness Based Stress Reduction to Reduce Burnout in Licensed Clinical Social Workers

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

This is a quasi-experimental study that will examine whether mindfulness based stress reduction, adapted to an online learning management system, will reduce factors related to burnout in private practice licensed clinical social workers in New York State.